Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Advancing Alternative Methods at FDA

Advancing Alternative Methods at FDA

                        About Alternative Methods
          Alternative Methods Partnerships
          Implementing Alternative Methods
          FDA’s Alternative Methods Forum Series
          Alternative Methods Publications and Events
          Publications Co-authored by FDA on Alternative Methods Home
          Science & Research
          About Science & Research at FDA
          Advancing Alternative Methods at FDA
          FDA’s Alternative Methods Forum SeriesAdvancing Alternative Methods at FDA FDA’s Alternative Methods Forum Series
  
  	
    Share
    Post
    Linkedin

    Email
    PrintImage
              Microphone on podium before webinar audience


  Caption
        
      Promoting cutting-edge technologies for disease modeling, efficacy, and safetyAn Opportunity for Developers and FDA Scientists

As part of FDA’s commitment to promote novel technologies for potential regulatory use, FDA gives developers and others the opportunity to present their new methods and methodologies directly to FDA scientists.  Educational opportunities to hear more about new predictive in vitro, in vivo, and in silico methods is vital to ensuring that FDA regulators and researchers have a broad skill set and remain current with cutting-edge science and technology.

How to be Considered for Selection

To be considered for selection, please submit the following information to FDA at:

**Alternatives@fda.hhs.gov**

A description of your new method or methodology, including origin of cells (if appropriate), species of animal (if appropriate), etc.
	A description of the proposed context of use of your new method or methodology.
	A description of the regulatory issue/gap where it could have an impact on an important regulatory issue.
	Data from use of your method, including any publications.


Your participation in this webinar would mean that your new technology would be introduced to FDA and that individual FDA programs would have the option to contact you for further information.  However, your participation in FDA’s webinar series would not constitute FDA’s endorsement of your new method or methodology.   Nor would it mean that FDA would assist you in qualifying your new method for regulatory use.

FDA will respond within 60 days to your webinar submission, with either a request for more information, a potential time for your webinar, or a reason why your new technology might not qualify for this program.  Although every new technology is exciting to FDA, it may not be mature enough to be incorporated into this program at this time.

This new webinar series joins ongoing FDA initiatives to bring the latest innovative technology to its regulatory and research scientists.

Resources for You

Advancing Alternative Methods at FDA

FDA's Predictive Toxicology Roadmap

                                                                                  Content current as of:
      11/14/2023
              
              
Topic(s)
			  Public AwarenessAdvancing Alternative Methods at FDA

          
                        About Alternative Methods
          Alternative Methods Partnerships
          Implementing Alternative Methods
          FDA’s Alternative Methods Forum Series
          Alternative Methods Publications and Events
          Publications Co-authored by FDA on Alternative Methods
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop